Community-associated methicillin-resistant Staphylococcus aureus, Canada

Emerging Infectious Diseases

Volumn 11, Issue 6, 2005, Pages 844-850

  Mulvey, Michael R ^a   MacDougall, Laura ^b,c   Cholin, Brenda ^d   Horsman, Greg ^e   Fidyk, Melanie ^f   Woods, Shirley ^g   Antonishyn, N ^e   Du, T ^a   Embil, J ^h   Graessli, A ^h   Irvine, J ⁱ   Khan, M ^f   Martin, S ^f   McDonald, R ^e   Nsungu, M ^g   Paton, S ^j   Celin, C ^a   Spreitzer, D ^a   Stockdale, D ⁱ  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c HEALTH CANADA   (Canada)

^d Saskatchewan   (Canada)

^e Saskatchewan Health   (Canada)

^f Kelsey Trail Health Region   (Canada)

^g Northern Intertribal Health Authority   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ Keewatin Yatthe and Mamaweetan Churchill Regional Health Authority   (Canada)

^j PUBLIC HEALTH AGENCY OF CANADA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CANADA; CONTROLLED STUDY; GENETIC ANALYSIS; HOSPITAL INFECTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PULSED FIELD GEL ELECTROPHORESIS; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

EID: 21144454516     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1106.041146     Document Type: Article

References (33)

1. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect. 1993;25:97-108.
2. Baggett HC, Hennessy TW, Leman R, Hamlin C, Bruden D, Reasonover A, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol. 2003;24:397-402.
3. Fergie JE, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J. 2001;20:860-3.
4. Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J. 2001;20:763-7.
5. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep. 1999;48:707-10.
6. Gwynne-Jones DP, Stott NS. Community-acquired methicillin-resistant Staphylococcus aureus: a cause of musculoskeletal sepsis in children. J Pediatr Orthop. 1999;19:413-6.
7. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis. 2001;33:990-6.
8. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819-24.
9. Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents. 2000;16:83-10.
10. Embil J, Ramotar K, Romance L, Alfa M, Conly J, Cronk S, et al. Methicillin-resistant S. aureus intertertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol. 1994;15:646-51.
11. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med. 1999;153:864-8.
12. Cooper CL, Dyck B, Ormiston D, Olekson K, McLeod J, Nicolle LE, et al. Bed utilization of patients with methicillin-resistant S. aureus (MRSA) in a Canadian tertiary care centre. Infect Control Hosp Epidemiol. 2002;23:483-4.
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically [approved standard M7-A5]. 5th ed. Wayne (PA): The Committee; 2000.
14. Walker ES, Levy F, Shorman M, David G, Abdalla J, Sarubbi FA. A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions. J Clin Microbiol. 2004;42:2792-5.
15. Lina G, Piemont Y, Godail-Gamont F, Bes M, Peter M-O, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-32.
16. Becker K, Roth R., Peters G. Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J Clin Microbiol. 1998;36:2548-53.
17. Mulvey MR, Chui L, Ismail J, Louie L, Murphy C, Chang N, et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J. Clin. Microbiol. 2001;39:3481-5.
18. Tenover FC, Arbeit RD, Goering RV, Mickelson PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
19. Simor AE, Ofner-Agostini M, Bryce E, McGeer A, Paton S, Mulvey MR, et al. Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of national surveillance, 1995-1999. J Infect Dis. 2002;186:652-60.
20. Simor AE, Boyd D, Louie L, McGeer A, Mulvey M, Willey BM. Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Can J Infect Dis. 1999;10:333-6
21. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin- susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2002;38:1008-15.
22. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46:2155-61.
23. Christianson S, Mulvey MR. A comparative genomic hybridization study of epidemic strains of methicillin-resistant Staphylococcus aureus in Canada. 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, May 1-4, 2004. Poster no. P1012.
24. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;25:1819-27.
25. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113-20.
26. Kurbis CA, Wylie JL. Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Can J Infect Dis. 2001;12:149-52.
27. Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002;46,1147-52.
28. Deplano A, Tassios PT, Glupczynski Y, Godfroid E, Struelens MJ. In vivo deletion of the methicillin resistance mec region from the chromosome of Staphylococcus aureus strains. J Antimicrob Chemother. 2000;46:617-20.
29. Inglis B, el-Adhami W, Stewart PR. Methicillin-sensitive and -resistant homologues of Staphylococcus aureus occur together among clinical isolates. J Infect Dis. 1993;67:323-8.
30. Udo EE, Al-Sweih N, Noronha BC. 1999. A chromosomal location of the mupA gene in Staphylococcus aureus expressing high-level mupirocin resistance. J Antimicrob Chemother. 2003;51:1283-6.
31. Gilbart J, Perry CR, Slocombe B. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob Agents Chemother. 1993;37:32-8.
32. Udo EE, Farook VS, Mokadas EM, Jacob LE, Sanyal SC. Molecular fingerprinting of mupirocin-resistant methicillin-resistant Staphylococcus aureus from a burn unit. Int J Infect Dis. 1998-1999;3:82-7.
33. Mulvey MR, Bryce E, Boyd D, Ofner-Agostini M, Christianson S, Simor AE, et al. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother. 2004;48:1204-14.